Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220017553 220008309 null 104.2 Curative (C) 2015-06-10 2015-06-10 Cyclophosphamide+Fludara+TBI Allo N null 220031581 CYCLOPHOSPHAMIDE + FLUDARABINE
220017554 220008310 1.64 60.3 Curative (C) 2013-07-10 2013-10-25 RUXOLITINIB 01 N 220031587 RUXOLITINIB
220017555 220008312 1.95 72.4 Disease modification (D) 2016-05-26 2016-05-26 IDARUBICIN + TRETINOIN N N 220031588 IDARUBICIN + TRETINOIN
220017556 220017930 1.8 16.9 Adjuvant (A) 2015-08-26 2015-10-07 ATG + Busulfan + Fludarabine N Y 220031603 ATG + BUSULFAN + FLUDARABINE
220017557 220008318 null 81.4 Not known (9) 2014-10-03 2014-10-04 AML16 DA 3+8 null null 220031606 AML16 TRIAL
220017558 220008320 null 68.5 Palliative (P) 2013-06-21 2013-06-22 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220031607 CYCLOPHOSPHAMIDE + FLUDARABINE
220017559 220008325 null null Palliative (P) 2018-08-05 2019-05-07 BOSUTINIB N null 220031609 BOSUTINIB
220017560 220017933 1.8 66.4 Palliative (P) 2018-10-28 2018-11-03 BOSUTINIB 02 N 220031612 BOSUTINIB
220017561 220008326 1.6 54.6 Palliative (P) 2014-11-16 2014-11-22 BOSUTINIB null N 220031621 BOSUTINIB
220017562 220008330 1.64 null Not known (9) 2017-06-15 2017-11-20 BOSUTINIB 02 N 220031623 BOSUTINIB
220017563 220008331 1.8 68.8 Curative (C) 2017-12-22 2018-02-14 IDARUBICIN + TRETINOIN N N 220031625 IDARUBICIN + TRETINOIN
220017564 220014526 1.5 17.05 Curative (C) 2016-07-14 2016-07-14 IDARUBICIN + TRETINOIN 02 N 220031628 IDARUBICIN + TRETINOIN
220017565 220008335 1.62 null Curative (C) 2017-04-04 2017-05-09 FLAG Y N 220031645 FLAG
220017567 220008337 1.66 54.8 Disease modification (D) 2016-12-12 2016-12-12 ATG + Busulfan + Fludarabine N null 220031653 ATG + BUSULFAN + FLUDARABINE
220017568 220008339 1.63 71.45 Curative (C) 2014-02-21 2014-02-21 BOSUTINIB N N 220031663 BOSUTINIB
220017569 220014530 1.68 67 Disease modification (D) 2014-10-02 2014-11-14 BOSUTINIB N N 220031680 BOSUTINIB
220017570 220019843 0 null Curative (C) 2016-10-26 2016-12-06 FLAG 2 N 220031681 FLAG
220017571 220008344 1.65 78.5 Curative (C) 2013-04-04 2013-04-04 ATG + Busulfan + Fludarabine N N 220031687 ATG + BUSULFAN + FLUDARABINE
220017572 220008349 null null null 2014-11-13 2014-11-13 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220031688 CYCLOPHOSPHAMIDE + FLUDARABINE
220017573 220008351 1.25 66.1 Curative (C) 2014-11-03 2017-05-24 ATG + Busulfan + Fludarabine N null 220031700 ATG + BUSULFAN + FLUDARABINE
220017574 220008353 0 0 Disease modification (D) 2017-01-09 2017-01-09 Cyclophosphamide TBI Allograft 02 N 220031700 CYCLOPHOSPHAMIDE
220017575 220008357 1.01 73.5 null 2016-10-28 2017-02-12 BOSUTINIB Y N 220031734 BOSUTINIB
220017576 220008358 1.57 0 Curative (C) 2013-09-29 2013-09-30 Idarubicin+Tretinoin Spanish Crse4 Y N 220031735 IDARUBICIN + TRETINOIN
220017577 220008361 1.5 60.8 Curative (C) 2014-05-13 2014-06-25 RUXOLITINIB N Y 220031736 RUXOLITINIB
220017578 220008362 0 null Disease modification (D) 2013-04-13 2013-07-04 CYCLOPHOSPHAMIDE + FLUDARABINE 01 N 220031736 CYCLOPHOSPHAMIDE + FLUDARABINE
220017581 220008367 1.67 78 Curative (C) 2014-03-09 2014-03-09 ATG + Busulfan + Fludarabine 02 N 220031749 ATG + BUSULFAN + FLUDARABINE
220017582 220014541 1.72 null Curative (C) 2017-10-04 2017-10-10 Cyclophosphamide+Fludara+TBI Allo N null 220031749 CYCLOPHOSPHAMIDE + FLUDARABINE
220017583 220014542 null 82 Curative (C) null 2014-01-21 Triple / Double Intrathecal Therapy N null 220031774 TRIPLE INTRATHECAL
220017584 220008370 1.56 54 Curative (C) 2014-07-04 2014-07-04 Triple Intrathecal 02 N 220031784 TRIPLE INTRATHECAL
220017585 220008374 null 10.6 Curative (C) 2012-11-22 2013-05-17 AML16 DA 2+5 N null 220031792 AML16 TRIAL
220017586 220008377 1.68 63.1 Curative (C) 2016-06-20 2016-06-21 AML16 Low Dose Cytarabine N null 220031796 AML16 TRIAL
220017587 220008378 1.6 60 Palliative (P) null 2018-10-21 BOSUTINIB N N 220031797 BOSUTINIB
220017588 220008381 0 8.3 Disease modification (D) 2014-02-02 2014-02-02 FLAG 02 N 220031799 FLAG
220017590 220008388 1.52 63.5 Disease modification (D) 2018-09-20 2018-09-20 AML16 DA 3+10 02 N 220031813 AML16 TRIAL
220017593 220008391 1.65 14.6 Adjuvant (A) 2016-03-24 2016-04-20 BOSUTINIB N N 220031820 BOSUTINIB
220017594 220017949 1.81 68.8 Curative (C) 2014-01-11 2014-01-11 Methotrexate intrathecal N Y 220031821 METHOTREXATE INTRATHECAL
220017595 220008395 null 90.4 Curative (C) 2010-05-25 2013-12-30 FLAG N N 220031843 FLAG
220017596 220008395 1.65 67.6 Curative (C) 2016-05-28 2016-06-03 FLAG N N 220031843 FLAG
220017597 220008397 null 76.2 Curative (C) 2017-09-03 2017-12-28 Triple Intrathecal N null 220031869 TRIPLE INTRATHECAL
220017598 220014552 1.6 null Curative (C) 2017-03-07 2017-08-07 AML16 DA 3+10 N N 220031880 AML16 TRIAL
220017599 220014553 1.79 73.6 Palliative (P) 2014-07-17 2014-07-18 Cyclophosphamide+Fludara+TBI Allo N N 220031880 CYCLOPHOSPHAMIDE + FLUDARABINE
220017600 220014554 null 106.8 Curative (C) 2015-09-17 2015-09-18 Triple Intrathecal N N 220031890 TRIPLE INTRATHECAL
220017601 220019856 1.56 25.8 null 2018-03-02 2018-07-12 BOSUTINIB N N 220031895 BOSUTINIB
220017602 220008403 1.74 41 Curative (C) 2015-09-27 2015-09-27 CYCLOPHOSPHAMIDE N N 220031895 CYCLOPHOSPHAMIDE
220017603 220008406 null 102 Disease modification (D) 2016-09-06 2016-09-06 IDARUBICIN + TRETINOIN N N 220031907 IDARUBICIN + TRETINOIN
220017604 220008407 1.73 0 null 2014-09-24 2014-09-30 CYCLOPHOSPHAMIDE + FLUDARABINE N Y 220031919 CYCLOPHOSPHAMIDE + FLUDARABINE
220017605 220008408 1.7 83 Disease modification (D) 2013-11-18 2013-12-04 Idarubicin+Tretinoin Spanish Crse4 02 N 220031924 IDARUBICIN + TRETINOIN
220017606 220008413 null 87.3 Disease modification (D) 2016-02-20 2016-04-02 IDARUBICIN + TRETINOIN N null 220031935 IDARUBICIN + TRETINOIN
220017609 220017958 1.78 82.2 Curative (C) 2016-12-19 2017-01-27 Triple Intrathecal 02 N 220031947 TRIPLE INTRATHECAL
220017610 220008423 1.79 53.6 Disease modification (D) 2014-07-29 2014-11-19 AML Int Guide ADE 10+3+5 (1) N N 220031952 ADE